|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong MCS, Huang J, Lok V, Wang J, Fung F,
Ding H and Zheng ZJ: Differences in incidence and mortality trends
of colorectal cancer worldwide based on sex, age, and anatomic
location. Clin Gastroenterol Hepatol. 19:955–966.e61. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakayama M, Wang D, Kok SY, Oshima H and
Oshima M: Genetic alterations and microenvironment that drive
malignant progression of colorectal cancer: Lessons from mouse and
organoid models. J Cancer Prev. 27:1–6. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeyakumar A, Dissabandara L and Gopalan V:
A critical overview on the biological and molecular features of red
and processed meat in colorectal carcinogenesis. J Gastroenterol.
52:407–418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen H, Zheng X, Zong X, Li Z, Li N, Hur
J, Fritz CD, Chapman W Jr, Nickel KB, Tipping A, et al: Metabolic
syndrome, metabolic comorbid conditions and risk of early-onset
colorectal cancer. Gut. 70:1147–1154. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roney MSI, Lanagan C, Sheng YH, Lawler K,
Schmidt C, Nguyen NT, Begun J and Kijanka GS: IgM and IgA augmented
autoantibody signatures improve early-stage detection of colorectal
cancer prior to nodal and distant spread. Clin Transl Immunology.
10:e13302021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
DeStefanis RA, Kratz JD, Olson AM, Sunil
A, DeZeeuw AK, Gillette AA, Sha GC, Johnson KA, Pasch CA, Clipson
L, et al: Impact of baseline culture conditions of cancer organoids
when determining therapeutic response and tumor heterogeneity. Sci
Rep. 12:52052022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ben-David U, Ha G, Tseng YY, Greenwald NF,
Oh C, Shih J, McFarland JM, Wong B, Boehm JS, Beroukhim R and Golub
TR: Patient-derived xenografts undergo mouse-specific tumor
evolution. Nat Genet. 49:1567–1575. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu H, Jiao Y, Qin S, Zhao W, Chu Q and Wu
K: Organoid technology in disease modelling, drug development,
personalized treatment and regeneration medicine. Exp Hematol
Oncol. 7:302018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li M and Izpisua Belmonte JC:
Organoids-Preclinical models of human disease. N Engl J Med.
380:569–579. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng D, Gleyzer R, Tai WH, Kumar P, Bian
Q, Isaacs B, da Rocha EL, Cai S, DiNapoli K, Huang FW and Cahan P:
Evaluating the transcriptional fidelity of cancer models. Genome
Med. 13:732021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Janakiraman H, Zhu Y, Becker SA, Wang C,
Cross A, Curl E, Lewin D, Hoffman BJ, Warren GW, Hill EG, et al:
Modeling rectal cancer to advance neoadjuvant precision therapy.
Int J Cancer. 147:1405–1418. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Veninga V and Voest EE: Tumor organoids:
Opportunities and challenges to guide precision medicine. Cancer
Cell. 39:1190–1201. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fontoura JC, Viezzer C, Dos Santos FG,
Ligabue RA, Weinlich R, Puga RD, Antonow D, Severino P and Bonorino
C: Comparison of 2D and 3D cell culture models for cell growth,
gene expression and drug resistance. Mater Sci Eng C Mater Biol
Appl. 107:1102642020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao H, Yan C, Hu Y, Mu L, Huang K, Li Q,
Li X, Tao D and Qin J: Sphere-forming assay vs. organoid culture:
Determining long-term stemness and the chemoresistant capacity of
primary colorectal cancer cells. Int J Oncol. 54:893–904.
2019.PubMed/NCBI
|
|
17
|
Lehmann R, Lee CM, Shugart EC, Benedetti
M, Charo RA, Gartner Z, Hogan B, Knoblich J, Nelson CM and Wilson
KM: Human organoids: A new dimension in cell biology. Mol Biol
Cell. 30:1129–1137. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Joshi R, Castro De Moura M, Piñeyro D,
Alvarez-Errico D, Arribas C and Esteller M: The DNA methylation
landscape of human cancer organoids available at the American type
culture collection. Epigenetics. 15:1167–1177. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lancaster MA and Knoblich JA:
Organogenesis in a dish: Modeling development and disease using
organoid technologies. Science. 345:12471252014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shirure VS, Hughes CCW and George SC:
Engineering Vascularized Organoid-on-a-Chip Models. Annu Rev Biomed
Eng. 23:141–167. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lancaster MA and Knoblich JA: Generation
of cerebral organoids from human pluripotent stem cells. Nat
Protoc. 9:2329–2340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sugimoto S and Sato T: Establishment of 3D
intestinal organoid cultures from intestinal stem cells. Methods
Mol Biol. 1612:97–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saito Y, Onishi N, Takami H, Seishima R,
Inoue H, Hirata Y, Kameyama K, Tsuchihashi K, Sugihara E, Uchino S,
et al: Development of a functional thyroid model based on an
organoid culture system. Biochem Biophys Res Commun. 497:783–789.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mazzucchelli S, Piccotti F, Allevi R,
Truffi M, Sorrentino L, Russo L, Agozzino M, Signati L, Bonizzi A,
Villani L and Corsi F: Establishment and morphological
characterization of patient-derived organoids from breast cancer.
Biol Proced Online. 21:122019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Seidlitz T, Merker SR, Rothe A, Zakrzewski
F, von Neubeck C, Grützmann K, Sommer U, Schweitzer C, Schölch S,
Uhlemann H, et al: Human gastric cancer modelling using organoids.
Gut. 68:207–217. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Broutier L, Andersson-Rolf A, Hindley CJ,
Boj SF, Clevers H, Koo BK and Huch M: Culture and establishment of
self-renewing human and mouse adult liver and pancreas 3D organoids
and their genetic manipulation. Nat Protoc. 11:1724–1743. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kopper O, de Witte CJ, Lõhmussaar K,
Valle-Inclan JE, Hami N, Kester L, Balgobind AV, Korving J, Proost
N, Begthel H, et al: An organoid platform for ovarian cancer
captures intra- and interpatient heterogeneity. Nat Med.
25:838–849. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takasato M, Er PX, Chiu HS, Maier B,
Baillie GJ, Ferguson C, Parton RG, Wolvetang EJ, Roost MS, Chuva de
Sousa Lopes SM and Little MH: Kidney organoids from human iPS cells
contain multiple lineages and model human nephrogenesis. Nature.
526:564–568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li X, Francies HE, Secrier M, Perner J,
Miremadi A, Galeano-Dalmau N, Barendt WJ, Letchford L, Leyden GM,
Goffin EK, et al: Organoid cultures recapitulate esophageal
adenocarcinoma heterogeneity providing a model for clonality
studies and precision therapeutics. Nat Commun. 9:29832018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Christin JR and Shen MM: Modeling tumor
plasticity in organoid models of human cancer. Trends Cancer.
8:161–163. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kakni P, Hueber R, Knoops K,
López-Iglesias C, Truckenmüller R, Habibovic P and Giselbrecht S:
Intestinal organoid culture in polymer film-based microwell arrays.
Adv Biosyst. 4:e20001262020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stevens CE and Leblond CP: Rate of renewal
of the cells of the intestinal epithelium in the rat. Anat Rec.
97:3731947.PubMed/NCBI
|
|
33
|
Li X, Larsson P, Ljuslinder I, Öhlund D,
Myte R, Löfgren-Burström A, Zingmark C, Ling A, Edin S and
Palmqvist R: Ex vivo organoid cultures reveal the importance of the
tumor microenvironment for maintenance of colorectal cancer stem
cells. Cancers (Basel). 12:9232020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Barker N, van Es JH, Kuipers J, Kujala P,
van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H,
Peters PJ and Clevers H: Identification of stem cells in small
intestine and colon by marker gene Lgr5. Nature. 449:1003–1007.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sato T, Vries RG, Snippert HJ, van de
Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters
PJ and Clevers H: Single Lgr5 stem cells build crypt-villus
structures in vitro without a mesenchymal niche. Nature.
459:262–265. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jung P, Sato T, Merlos-Suárez A, Barriga
FM, Iglesias M, Rossell D, Auer H, Gallardo M, Blasco MA, Sancho E,
et al: Isolation and in vitro expansion of human colonic stem
cells. Nat Med. 17:1225–1227. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sato T, Stange DE, Ferrante M, Vries RG,
Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J,
Siersema PD and Clevers H: Long-term expansion of epithelial
organoids from human colon, adenoma, adenocarcinoma, and Barrett's
epithelium. Gastroenterology. 141:1762–1772. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grabinger T, Luks L, Kostadinova F,
Zimberlin C, Medema JP, Leist M and Brunner T: Ex vivo culture of
intestinal crypt organoids as a model system for assessing cell
death induction in intestinal epithelial cells and enteropathy.
Cell Death Dis. 5:e12282014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ganesh K, Wu C, O'Rourke KP, Szeglin BC,
Zheng Y, Sauvé CG, Adileh M, Wasserman I, Marco MR, Kim AS, et al:
A rectal cancer organoid platform to study individual responses to
chemoradiation. Nat Med. 25:1607–1614. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fujii M, Matano M, Nanki K and Sato T:
Efficient genetic engineering of human intestinal organoids using
electroporation. Nat Protoc. 10:1474–1485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
van de Wetering M, Francies HE, Francis
JM, Bounova G, Iorio F, Pronk A, van Houdt W, van Gorp J,
Taylor-Weiner A, Kester L, et al: Prospective derivation of a
living organoid biobank of colorectal cancer patients. Cell.
161:933–945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xie BY and Wu AW: Organoid culture of
isolated cells from patient-derived tissues with colorectal cancer.
Chin Med J (Engl). 129:2469–2475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huch M, Dorrell C, Boj SF, van Es JH, Li
VS, van de Wetering M, Sato T, Hamer K, Sasaki N, Finegold MJ, et
al: In vitro expansion of single Lgr5+ liver stem cells induced by
Wnt-driven regeneration. Nature. 494:247–250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huch M, Bonfanti P, Boj SF, Sato T,
Loomans CJ, van de Wetering M, Sojoodi M, Li VS, Schuijers J,
Gracanin A, et al: Unlimited in vitro expansion of adult bi-potent
pancreas progenitors through the Lgr5/R-spondin axis. EMBO J.
32:2708–2721. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Amsterdam A, Raanan C, Schreiber L,
Freyhan O, Schechtman L and Givol D: Localization of the stem cell
markers LGR5 and Nanog in the normal and the cancerous human ovary
and their inter-relationship. Acta Histochem. 115:330–338. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Koo BK, Stange DE, Sato T, Karthaus W,
Farin HF, Huch M, van Es JH and Clevers H: Controlled gene
expression in primary Lgr5 organoid cultures. Nat Methods. 9:81–83.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Barker N, Rookmaaker MB, Kujala P, Ng A,
Leushacke M, Snippert H, van de Wetering M, Tan S, Van Es JH, Huch
M, et al: Lgr5(+ve) stem/progenitor cells contribute to nephron
formation during kidney development. Cell Rep. 2:540–552. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kadur Lakshminarasimha Murthy P, Sontake
V, Tata A, Kobayashi Y, Macadlo L, Okuda K, Conchola AS, Nakano S,
Gregory S, Miller LA, et al: Human distal lung maps and lineage
hierarchies reveal a bipotent progenitor. Nature. 604:111–119.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Leung C, Tan SH and Barker N: Recent
advances in Lgr5+ stem cell research. Trends Cell Biol.
28:380–391. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schutgens F and Clevers H: Human
organoids: Tools for understanding biology and treating diseases.
Annu Rev Pathol. 15:211–234. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Crespo M, Vilar E, Tsai SY, Chang K, Amin
S, Srinivasan T, Zhang T, Pipalia NH, Chen HJ, Witherspoon M, et
al: Colonic organoids derived from human induced pluripotent stem
cells for modeling colorectal cancer and drug testing. Nat Med.
23:878–884. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Daoud A and Múnera JO: Generation of human
colonic organoids from human pluripotent stem cells. Methods Cell
Biol. 159:201–227. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Spence JR, Mayhew CN, Rankin SA, Kuhar MF,
Vallance JE, Tolle K, Hoskins EE, Kalinichenko VV, Wells SI, Zorn
AM, et al: Directed differentiation of human pluripotent stem cells
into intestinal tissue in vitro. Nature. 470:105–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Múnera JO, Sundaram N, Rankin SA, Hill D,
Watson C, Mahe M, Vallance JE, Shroyer NF, Sinagoga KL,
Zarzoso-Lacoste A, et al: Differentiation of human pluripotent stem
cells into colonic organoids via transient activation of BMP
signaling. Cell Stem Cell. 21:51–64.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fujii M, Shimokawa M, Date S, Takano A,
Matano M, Nanki K, Ohta Y, Toshimitsu K, Nakazato Y, Kawasaki K, et
al: A colorectal tumor organoid library demonstrates progressive
loss of niche factor requirements during tumorigenesis. Cell Stem
Cell. 18:827–838. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Matano M, Date S, Shimokawa M, Takano A,
Fujii M, Ohta Y, Watanabe T, Kanai T and Sato T: Modeling
colorectal cancer using CRISPR-Cas9-mediated engineering of human
intestinal organoids. Nat Med. 21:256–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Drost J, van Jaarsveld RH, Ponsioen B,
Zimberlin C, van Boxtel R, Buijs A, Sachs N, Overmeer RM, Offerhaus
GJ, Begthel H, et al: Sequential cancer mutations in cultured human
intestinal stem cells. Nature. 521:43–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yan HHN, Siu HC, Ho SL, Yue SSK, Gao Y,
Tsui WY, Chan D, Chan AS, Wong JWH, Man AHY, et al: Organoid
cultures of early-onset colorectal cancers reveal distinct and rare
genetic profiles. Gut. 69:2165–2179. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Weeber F, van de Wetering M, Hoogstraat M,
Dijkstra KK, Krijgsman O, Kuilman T, Gadellaa-van Hooijdonk CG, van
der Velden DL, Peeper DS, Cuppen EP, et al: Preserved genetic
diversity in organoids cultured from biopsies of human colorectal
cancer metastases. Proc Natl Acad Sci USA. 112:13308–13311. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang R, Mao Y, Wang W, Zhou X, Wang W, Gao
S, Li J, Wen L, Fu W and Tang F: Systematic evaluation of
colorectal cancer organoid system by single-cell RNA-Seq analysis.
Genome Biol. 23:1062022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cristobal A, van den Toorn HWP, van de
Wetering M, Clevers H, Heck AJR and Mohammed S: Personalized
proteome profiles of healthy and tumor human colon organoids reveal
both individual diversity and basic features of colorectal cancer.
Cell Rep. 18:263–274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jabaji Z, Sears CM, Brinkley GJ, Lei NY,
Joshi VS, Wang J, Lewis M, Stelzner M, Martín MG and Dunn JC: Use
of collagen gel as an alternative extracellular matrix for the in
vitro and in vivo growth of murine small intestinal epithelium.
Tissue Eng Part C Methods. 19:961–969. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Brown JW and Mills JC: Implantable
synthetic organoid matrices for intestinal regeneration. Nat Cell
Biol. 19:1307–1308. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Roper J, Tammela T, Cetinbas NM, Akkad A,
Roghanian A, Rickelt S, Almeqdadi M, Wu K, Oberli MA,
Sánchez-Rivera FJ, et al: In vivo genome editing and organoid
transplantation models of colorectal cancer and metastasis. Nat
Biotechnol. 35:569–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Barbáchano A, Fernández-Barral A,
Bustamante-Madrid P, Prieto I, Rodríguez-Salas N, Larriba MJ and
Muñoz A: Organoids and colorectal cancer. Cancers (Basel).
13:26572021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kapoor-Narula U and Lenka N: Cancer stem
cells and tumor heterogeneity: Deciphering the role in tumor
progression and metastasis. Cytokine. 157:1559682022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zeuner A, Todaro M, Stassi G and De Maria
R: Colorectal cancer stem cells: From the crypt to the clinic. Cell
Stem Cell. 15:692–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Punt CJA, Koopman M and Vermeulen L: From
tumour heterogeneity to advances in precision treatment of
colorectal cancer. Nat Rev Clin Oncol. 14:235–246. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Pleguezuelos-Manzano C, Puschhof J,
Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C,
Manders F, Dalmasso G, Stege PB, et al: Mutational signature in
colorectal cancer caused by genotoxic pks+ E. coli.
Nature. 580:269–273. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wang R, Li J, Zhou X, Mao Y, Wang W, Gao
S, Wang W, Gao Y, Chen K, Yu S, et al: Single-cell genomic and
transcriptomic landscapes of primary and metastatic colorectal
cancer tumors. Genome Med. 14:932022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Youk J, Kwon HW, Kim R and Ju YS:
Dissecting single-cell genomes through the clonal organoid
technique. Exp Mol Med. 53:1503–1511. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Roerink SF, Sasaki N, Lee-Six H, Young MD,
Alexandrov LB, Behjati S, Mitchell TJ, Grossmann S, Lightfoot H,
Egan DA, et al: Intra-tumour diversification in colorectal cancer
at the single-cell level. Nature. 556:457–462. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ono H, Arai Y, Furukawa E, Narushima D,
Matsuura T, Nakamura H, Shiokawa D, Nagai M, Imai T, Mimori K, et
al: Single-cell DNA and RNA sequencing reveals the dynamics of
intra-tumor heterogeneity in a colorectal cancer model. BMC Biol.
19:2072021. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Demmers LC, Kretzschmar K, Van Hoeck A,
Bar-Epraïm YE, van den Toorn HWP, Koomen M, van Son G, van Gorp J,
Pronk A, Smakman N, et al: Single-cell derived tumor organoids
display diversity in HLA class I peptide presentation. Nat Commun.
11:53382020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Greaves M: Evolutionary determinants of
cancer. Cancer Discov. 5:806–820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
McGranahan N and Swanton C: Clonal
heterogeneity and tumor evolution: Past, present, and the future.
Cell. 168:613–628. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Kim SC, Park JW, Seo HY, Kim M, Park JH,
Kim GH, Lee JO, Shin YK, Bae JM, Koo BK, et al: Multifocal organoid
capturing of colon cancer reveals pervasive intratumoral
heterogenous drug responses. Adv Sci (Weinh). 9:e21033602022.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Jeong N, Kim SC, Park JW, Park SG, Nam KH,
Lee JO, Shin YK, Bae JM, Jeong SY, Kim MJ and Ku JL: Multifocal
organoids reveal clonal associations between synchronous intestinal
tumors with pervasive heterogeneous drug responses. NPJ Genom Med.
7:422022. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Okamoto T, duVerle D, Yaginuma K, Natsume
Y, Yamanaka H, Kusama D, Fukuda M, Yamamoto M, Perraudeau F,
Srivastava U, et al: Comparative analysis of patient-matched PDOs
revealed a reduction in OLFM4-Associated clusters in metastatic
lesions in colorectal cancer. Stem Cell Reports. 16:954–967. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Mo S, Tang P, Luo W, Zhang L, Li Y, Hu X,
Ma X, Chen Y, Bao Y, He X, et al: Patient-Derived organoids from
colorectal cancer with paired liver metastasis reveal tumor
heterogeneity and predict response to chemotherapy. Adv Sci
(Weinh). 9:e22040972022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Fumagalli A, Drost J, Suijkerbuijk SJE,
van Boxtel R, de Ligt J, Offerhaus GJ, Begthel H, Beerling E, Tan
EH, Sansom OJ, et al: Genetic dissection of colorectal cancer
progression by orthotopic transplantation of engineered cancer
organoids. Proc Natl Acad Sci USA. 114:E2357–E2364. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Yao Y, Xu X, Yang L, Zhu J, Wan J, Shen L,
Xia F, Fu G, Deng Y, Pan M, et al: Patient-Derived organoids
predict chemoradiation responses of locally advanced rectal cancer.
Cell Stem Cell. 26:17–26.e6. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Sachs N, de Ligt J, Kopper O, Gogola E,
Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H,
et al: A living biobank of breast cancer organoids captures disease
heterogeneity. Cell. 172:373–386.e10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Mullenders J, de Jongh E, Brousali A,
Roosen M, Blom JPA, Begthel H, Korving J, Jonges T, Kranenburg O,
Meijer R and Clevers HC: Mouse and human urothelial cancer
organoids: A tool for bladder cancer research. Proc Natl Acad Sci
USA. 116:4567–4574. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang XW, Xia TL, Tang HC, Liu X, Han R,
Zou X, Zhao YT, Chen MY and Li G: Establishment of a
patient-derived organoid model and living biobank for
nasopharyngeal carcinoma. Ann Transl Med. 10:5262022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Beato F, Reverón D, Dezsi KB, Ortiz A,
Johnson JO, Chen DT, Ali K, Yoder SJ, Jeong D, Malafa M, et al:
Establishing a living biobank of patient-derived organoids of
intraductal papillary mucinous neoplasms of the pancreas. Lab
Invest. 101:204–217. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Li YF, Gao Y, Liang BW, Cao XQ, Sun ZJ, Yu
JH, Liu ZD and Han Y: Patient-derived organoids of non-small cells
lung cancer and their application for drug screening. Neoplasma.
67:430–437. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Yan HHN, Siu HC, Law S, Ho SL, Yue SSK,
Tsui WY, Chan D, Chan AS, Ma S, Lam KO, et al: A Comprehensive
human gastric cancer organoid biobank captures tumor subtype
heterogeneity and enables therapeutic screening. Cell Stem Cell.
23:882–897.e11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Jacob F, Salinas RD, Zhang DY, Nguyen PTT,
Schnoll JG, Wong SZH, Thokala R, Sheikh S, Saxena D, Prokop S, et
al: A patient-derived glioblastoma organoid model and biobank
recapitulates inter- and intra-tumoral heterogeneity. Cell.
180:188–204.e22. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Vlachogiannis G, Hedayat S, Vatsiou A,
Jamin Y, Fernández-Mateos J, Khan K, Lampis A, Eason K, Huntingford
I, Burke R, et al: Patient-derived organoids model treatment
response of metastatic gastrointestinal cancers. Science.
359:920–926. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Luo L, Ma Y, Zheng Y, Su J and Huang G:
Application progress of organoids in colorectal cancer. Front Cell
Dev Biol. 10:8150672022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Seidlitz T and Stange DE: Gastrointestinal
cancer organoids-applications in basic and translational cancer
research. Exp Mol Med. 53:1459–1470. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Kong J, Lee H, Kim D, Han SK, Ha D, Shin K
and Kim S: Network-based machine learning in colorectal and bladder
organoid models predicts anti-cancer drug efficacy in patients. Nat
Commun. 11:54852020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Pasch CA, Favreau PF, Yueh AE, Babiarz CP,
Gillette AA, Sharick JT, Karim MR, Nickel KP, DeZeeuw AK,
Sprackling CM, et al: Patient-Derived cancer organoid cultures to
predict sensitivity to chemotherapy and radiation. Clin Cancer Res.
25:5376–5387. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ooft SN, Weeber F, Dijkstra KK, McLean CM,
Kaing S, van Werkhoven E, Schipper L, Hoes L, Vis DJ, van de Haar
J, et al: Patient-derived organoids can predict response to
chemotherapy in metastatic colorectal cancer patients. Sci Transl
Med. 11:eaay25742019. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Chen G, Gong T, Wang Z, Wang Z, Lin X,
Chen S, Sun C, Zhao W, Kong Y, Ai H, et al: Colorectal cancer
organoid models uncover oxaliplatin-resistant mechanisms at single
cell resolution. Cell Oncol (Dordr). 45:1155–1167. 2022.PubMed/NCBI
|
|
97
|
Lv T, Shen L, Xu X, Yao Y, Mu P, Zhang H,
Wan J, Wang Y, Guan R, Li X, et al: Patient-derived tumor organoids
predict responses to irinotecan-based neoadjuvant chemoradiotherapy
in patients with locally advanced rectal cancer. Int J Cancer.
152:524–535. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Hongmao S: A Practical Guide to Rational
Drug Design. Woodhead Publishing; 2015
|
|
99
|
Pauli C, Hopkins BD, Prandi D, Shaw R,
Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R, et al:
Personalized in vitro and in vivo cancer models to guide precision
medicine. Cancer Discov. 7:462–477. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Fielden MR and Kolaja KL: The role of
early in vivo toxicity testing in drug discovery toxicology. Expert
Opin Drug Saf. 7:107–110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Lu W, Rettenmeier E, Paszek M, Yueh MF,
Tukey RH, Trottier J, Barbier O and Chen S: Crypt organoid culture
as an in vitro model in drug metabolism and cytotoxicity studies.
Drug Metab Dispos. 45:748–754. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Schnalzger TE, de Groot MH, Zhang C, Mosa
MH, Michels BE, Röder J, Darvishi T, Wels WS and Farin HF: 3D model
for CAR-mediated cytotoxicity using patient-derived colorectal
cancer organoids. EMBO J. 38:e1009282019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Park M, Kwon J, Shin HJ, Moon SM, Kim SB,
Shin US, Han YH and Kim Y: Butyrate enhances the efficacy of
radiotherapy via FOXO3A in colorectal cancer patient-derived
organoids. Int J Oncol. 57:1307–1318. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
De Oliveira T, Goldhardt T, Edelmann M,
Rogge T, Rauch K, Kyuchukov ND, Menck K, Bleckmann A, Kalucka J,
Khan S, et al: Effects of the Novel PFKFB3 Inhibitor KAN0438757 on
colorectal cancer cells and its systemic toxicity evaluation in
vivo. Cancers (Basel). 13:10112021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Weeber F, Ooft SN, Dijkstra KK and Voest
EE: Tumor organoids as a pre-clinical cancer model for drug
discovery. Cell Chem Biol. 24:1092–1100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Rae C, Amato F and Braconi C:
Patient-Derived organoids as a model for cancer drug discovery. Int
J Mol Sci. 22:34832021. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Costales-Carrera A, Fernández-Barral A,
Bustamante-Madrid P, Guerra L, Cantero R, Barbáchano A and Muñoz A:
Plocabulin displays strong cytotoxic activity in a personalized
colon cancer patient-derived 3D Organoid Assay. Mar Drugs.
17:6482019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Zerp SF, Bibi Z, Verbrugge I, Voest EE and
Verheij M: Enhancing radiation response by a second-generation
TRAIL receptor agonist using a new in vitro organoid model system.
Clin Transl Radiat Oncol. 24:1–9. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Norkin M, Ordóñez-Morán P and Huelsken J:
High-content, targeted RNA-seq screening in organoids for drug
discovery in colorectal cancer. Cell Rep. 35:1090262021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Sailer V, Pauli C, Merzier EC, Mosquera
JM, Beltran H, Rubin MA and Rao RA: On-site cytology for
development of patient-derived three-dimensional organoid
cultures-A pilot study. Anticancer Res. 37:1569–1573. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Sholl LM, Aisner DL, Varella-Garcia M,
Berry LD, Dias-Santagata D, Wistuba II, Chen H, Fujimoto J, Kugler
K, Franklin WA, et al: Multi-institutional oncogenic driver
mutation analysis in lung adenocarcinoma: the lung cancer mutation
consortium experience. J Thorac Oncol. 10:768–777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Le DT, Uram JN, Wang H, Bartlett BR,
Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et
al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl
J Med. 372:2509–2520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Hsu KS, Adileh M, Martin ML, Makarov V,
Chen J, Wu C, Bodo S, Klingler S, Sauvé CG, Szeglin BC, et al:
Colorectal cancer develops inherent radiosensitivity that can be
predicted using patient-derived organoids. Cancer Res.
82:2298–2312. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Cho YW, Min DW, Kim HP, An Y, Kim S, Youk
J, Chun J, Im JP, Song SH, Ju YS, et al: Patient-derived organoids
as a preclinical platform for precision medicine in colorectal
cancer. Mol Oncol. 16:2396–2412. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Geevimaan K, Guo JY, Shen CN, Jiang JK,
Fann CSJ, Hwang MJ, Shui JW, Lin HT, Wang MJ, Shih HC, et al:
Patient-Derived organoid serves as a platform for personalized
chemotherapy in advanced colorectal cancer patients. Front Oncol.
12:8834372022. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Wang T, Pan W, Zheng H, Zheng H, Wang Z,
Li JJ, Deng C and Yan J: Accuracy of using a patient-derived tumor
organoid culture model to predict the response to chemotherapy
regimens in stage IV colorectal cancer: A blinded study. Dis Colon
Rectum. 64:833–850. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Bock C, Boutros M, Camp JG, Clarke L,
Clevers H, Knoblich JA, Liberali P, Regev A, Rios AC, Stegle O, et
al: The Organoid Cell Atlas. Nat Biotechnol. 39:13–17. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Price S, Bhosle S, Gonçalves E, Li X,
McClurg DP, Barthorpe S, Beck A, Hall C, Lightfoot H, Farrow L, et
al: A suspension technique for efficient large-scale cancer
organoid culturing and perturbation screens. Sci Rep. 12:55712022.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Ji DB and Wu AW: Organoid in colorectal
cancer: Progress and challenges. Chin Med J (Engl). 133:1971–1977.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Marinucci M, Ercan C, Taha-Mehlitz S,
Fourie L, Panebianco F, Bianco G, Gallon J, Staubli S, Soysal SD,
Zettl A, et al: Standardizing patient-derived organoid generation
workflow to avoid microbial contamination from colorectal cancer
tissues. Front Oncol. 11:7818332022. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Janda CY, Dang LT, You C, Chang J, de Lau
W, Zhong ZA, Yan KS, Marecic O, Siepe D, Li X, et al: Surrogate Wnt
agonists that phenocopy canonical Wnt and β-catenin signalling.
Nature. 545:234–237. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Gjorevski N, Nikolaev M, Brown TE,
Mitrofanova O, Brandenberg N, DelRio FW, Yavitt FM, Liberali P,
Anseth KS and Lutolf MP: Tissue geometry drives deterministic
organoid patterning. Science. 375:eaaw90212022. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Nikolaev M, Mitrofanova O, Broguiere N,
Geraldo S, Dutta D, Tabata Y, Elci B, Brandenberg N, Kolotuev I,
Gjorevski N, et al: Homeostatic mini-intestines through
scaffold-guided organoid morphogenesis. Nature. 585:574–578. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Kleinman HK and Martin GR: Matrigel:
Basement membrane matrix with biological activity. Semin Cancer
Biol. 15:378–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Heo JH, Kang D, Seo SJ and Jin Y:
Engineering the extracellular matrix for organoid culture. Int J
Stem Cells. 15:60–69. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Rathje F, Klingler S and Aberger F:
Organoids for Modeling (Colorectal) Cancer in a Dish. Cancers
(Basel). 14:54162022. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Ng S, Tan WJ, Pek MMX, Tan MH and Kurisawa
M: Mechanically and chemically defined hydrogel matrices for
patient-derived colorectal tumor organoid culture. Biomaterials.
219:1194002019. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Luo X, Fong ELS, Zhu C, Lin QXX, Xiong M,
Li A, Li T, Benoukraf T, Yu H and Liu S: Hydrogel-based colorectal
cancer organoid co-culture models. Acta Biomater. 132:461–472.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Tayler IM and Stowers RS: Engineering
hydrogels for personalized disease modeling and regenerative
medicine. Acta Biomater. 132:4–22. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Yang H, Zhang N and Liu YC: An organoids
biobank for recapitulating tumor heterogeneity and personalized
medicine. Chin J Cancer Res. 32:408–413. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Boers SN, van Delden JJM and Bredenoord
AL: Organoids as hybrids: Ethical implications for the exchange of
human tissues. J Med Ethics. 45:131–139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Botti G, Di Bonito M and Cantile M:
Organoid biobanks as a new tool for pre-clinical validation of
candidate drug efficacy and safety. Int J Physiol Pathophysiol
Pharmacol. 13:17–21. 2021.PubMed/NCBI
|
|
133
|
Wallaschek N, Niklas C, Pompaiah M,
Wiegering A, Germer CT, Kircher S, Brändlein S, Maurus K, Rosenwald
A, Yan HHN, et al: Establishing pure cancer organoid cultures:
Identification, selection and verification of cancer phenotypes and
genotypes. J Mol Biol. 431:2884–2893. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Driehuis E, Kretzschmar K and Clevers H:
Establishment of patient-derived cancer organoids for
drug-screening applications. Nat Protoc. 15:3380–3409. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Grigorian A and O'Brien CB: Hepatotoxicity
secondary to chemotherapy. J Clin Transl Hepatol. 2:95–102.
2014.PubMed/NCBI
|
|
136
|
Fiore D, Ramesh P, Proto MC, Piscopo C,
Franceschelli S, Anzelmo S, Medema JP, Bifulco M and Gazzerro P:
Rimonabant kills colon cancer stem cells without inducing toxicity
in normal colon organoids. Front Pharmacol. 8:9492018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Idris M, Alves MM, Hofstra RMW, Mahe MM
and Melotte V: Intestinal multicellular organoids to study
colorectal cancer. Biochim Biophys Acta Rev Cancer.
1876:1885862021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Zhang J, Tavakoli H, Ma L and Li X, Han L
and Li X: Immunotherapy discovery on tumor organoid-on-a-chip
platforms that recapitulate the tumor microenvironment. Adv Drug
Deliv Rev. 187:1143652022. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Junttila MR and de Sauvage FJ: Influence
of tumour micro-environment heterogeneity on therapeutic response.
Nature. 501:346–354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
LeSavage BL, Suhar RA, Broguiere N, Lutolf
MP and Heilshorn SC: Next-generation cancer organoids. Nat Mater.
21:143–159. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Bulin AL and Hasan T: Spatiotemporal
tracking of different cell populations in cancer organoid models
for investigations on photodynamic therapy. Methods Mol Biol.
2451:81–90. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Mosa MH, Michels BE, Menche C, Nicolas AM,
Darvishi T, Greten FR and Farin HF: A Wnt-Induced phenotypic switch
in cancer-associated fibroblasts inhibits EMT in colorectal cancer.
Cancer Res. 80:5569–5582. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Naruse M, Ochiai M, Sekine S, Taniguchi H,
Yoshida T, Ichikawa H, Sakamoto H, Kubo T, Matsumoto K, Ochiai A
and Imai T: Re-expression of REG family and DUOXs genes in CRC
organoids by co-culturing with CAFs. Sci Rep. 11:20772021.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Noel G, Baetz NW, Staab JF, Donowitz M,
Kovbasnjuk O, Pasetti MF and Zachos NC: A primary human
macrophage-enteroid co-culture model to investigate mucosal gut
physiology and host-pathogen interactions. Sci Rep. 7:452702017.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Neal JT, Li X, Zhu J, Giangarra V,
Grzeskowiak CL, Ju J, Liu IH, Chiou SH, Salahudeen AA, Smith AR, et
al: Organoid modeling of the tumor immune microenvironment. Cell.
175:1972–1988.e16. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Dijkstra KK, Cattaneo CM, Weeber F,
Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL,
Kaing S, Kelderman S, et al: Generation of tumor-reactive T cells
by co-culture of peripheral blood lymphocytes and tumor organoids.
Cell. 174:1586–1598.e12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Cattaneo CM, Dijkstra KK, Fanchi LF,
Kelderman S, Kaing S, van Rooij N, van den Brink S, Schumacher TN
and Voest EE: Tumor organoid-T-cell coculture systems. Nat Protoc.
15:15–39. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Frenkel N, Poghosyan S, Alarcón CR, García
SB, Queiroz K, van den Bent L, Laoukili J, Rinkes IB, Vulto P,
Kranenburg O and Hagendoorn J: Long-Lived human lymphatic
endothelial cells to study lymphatic biology and lymphatic
vessel/tumor coculture in a 3D microfluidic model. ACS Biomater Sci
Eng. 7:3030–3042. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Sontheimer-Phelps A, Hassell BA and Ingber
DE: Modelling cancer in microfluidic human organs-on-chips. Nat Rev
Cancer. 19:65–81. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Bein A, Shin W, Jalili-Firoozinezhad S,
Park MH, Sontheimer-Phelps A, Tovaglieri A, Chalkiadaki A, Kim HJ
and Ingber DE: Microfluidic Organ-on-a-Chip models of human
intestine. Cell Mol Gastroenterol Hepatol. 5:659–668. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Yan J, Li Z and Guo J, Liu S and Guo J:
Organ-on-a-chip: A new tool for in vitro research. Biosens
Bioelectron. 216:1146262022. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Park SE, Georgescu A and Huh D:
Organoids-on-a-chip. Science. 364:960–965. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Takebe T, Zhang B and Radisic M:
Synergistic engineering: Organoids Meet Organs-on-a-Chip. Cell Stem
Cell. 21:297–300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Karzbrun E, Kshirsagar A, Cohen SR, Hanna
JH and Reiner O: Human brain organoids on a chip reveal the physics
of folding. Nat Phys. 14:515–522. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Zhang YS, Aleman J, Shin SR, Kilic T, Kim
D, Mousavi Shaegh SA, Massa S, Riahi R, Chae S, Hu N, et al:
Multisensor-integrated organs-on-chips platform for automated and
continual in situ monitoring of organoid behaviors. Proc Natl Acad
Sci USA. 114:E2293–E2302. 2017.PubMed/NCBI
|
|
156
|
Skardal A, Shupe T and Atala A:
Organoid-on-a-chip and body-on-a-chip systems for drug screening
and disease modeling. Drug Discov Today. 21:1399–1411. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Rajasekar S, Lin DSY, Abdul L, Liu A,
Sotra A, Zhang F and Zhang B: IFlowPlate-A Customized 384-Well
Plate for the culture of perfusable vascularized colon organoids.
Adv Mater. 32:e20029742020. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Pinho D, Santos D, Vila A and Carvalho S:
Establishment of colorectal cancer organoids in microfluidic-based
system. Micromachines (Basel). 12:4972021. View Article : Google Scholar : PubMed/NCBI
|
